UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter) |
|
| |||
(State of other jurisdiction |
| (Commission |
| (IRS Employer |
of incorporation) |
| File Number) |
| Identification No.) |
| ||
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
|
| The |
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On September 26, 2023, the registrant (“Laser Photonics” or the “Company”) received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company no longer complies with Nasdaq’s audit committee requirement under Nasdaq’s Listing Rule 5605 following the resignation of Ryan Tennyson from the Company’s board of directors and audit committee effective September 20, 2023. Nasdaq advised Laser Photonics that in accordance with Nasdaq’s Listing Rule 5605(c)(4) the Company has a cure period to regain compliance (i) until the earlier of the Company's next annual shareholders’ meeting or September 20, 2024; or (ii) if the next annual shareholders’ meeting is held before March 18, 2024, then the Company must evidence compliance no later than March 18, 2024 (the “Cure Period”). The Company expects to identify a qualified candidate for this vacancy on its Board of Directors within the Cure Period.
Item 9.01 Financial Statements and Exhibits.
Exhibits
104 |
| Cover Page Interactive Data File (embedded within the Inline XBRL document) |
- 2 - |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
LASER PHOTONICS CORPORATION | |||
Date: September 29, 2023 | By: | /s/ Wayne Tupuola | |
|
| Wayne Tupuola | |
President and CEO |
- 3 - |